Erdong Shen

449 total citations
20 papers, 281 citations indexed

About

Erdong Shen is a scholar working on Surgery, Cancer Research and Oncology. According to data from OpenAlex, Erdong Shen has authored 20 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Erdong Shen's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Erdong Shen is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Erdong Shen collaborates with scholars based in China and Saint Kitts and Nevis. Erdong Shen's co-authors include Guolian Zhu, Xiaobo Lu, Zhe Sun, Xin Liu, Liang Zhang, Mingyang Xiao, Yongbin Hu, Lin Zhou, Pu Yang and Weidong Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Erdong Shen

19 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erdong Shen China 9 169 131 56 41 41 20 281
Zeng-Hong Li Hong Kong 13 226 1.3× 196 1.5× 37 0.7× 53 1.3× 19 0.5× 13 341
Chih-Yuan Fang Taiwan 13 169 1.0× 184 1.4× 63 1.1× 38 0.9× 13 0.3× 25 367
Valeria Denninghoff Argentina 9 51 0.3× 64 0.5× 58 1.0× 95 2.3× 20 0.5× 33 250
Hong-Lin Yin China 8 115 0.7× 64 0.5× 28 0.5× 50 1.2× 21 0.5× 27 228
Paul‐Yang Lin Taiwan 8 128 0.8× 53 0.4× 83 1.5× 130 3.2× 114 2.8× 8 335
Junhang Luo China 7 129 0.8× 74 0.6× 25 0.4× 49 1.2× 16 0.4× 12 191
Yuenan Huang China 9 159 0.9× 126 1.0× 46 0.8× 102 2.5× 19 0.5× 13 289
Ian Y. Luk Australia 9 134 0.8× 48 0.4× 35 0.6× 61 1.5× 33 0.8× 11 214
Xi He China 11 93 0.6× 84 0.6× 36 0.6× 149 3.6× 35 0.9× 31 312

Countries citing papers authored by Erdong Shen

Since Specialization
Citations

This map shows the geographic impact of Erdong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erdong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erdong Shen more than expected).

Fields of papers citing papers by Erdong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erdong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erdong Shen. The network helps show where Erdong Shen may publish in the future.

Co-authorship network of co-authors of Erdong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Erdong Shen. A scholar is included among the top collaborators of Erdong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erdong Shen. Erdong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouyang, Min, Hao Sun, Xiaoyu Liu, et al.. (2025). The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study. World Journal of Surgical Oncology. 23(1). 6–6.
2.
Luo, Pan, Ling Ni, Jianbin Hu, et al.. (2024). The clinical value of local consolidative therapy for oligo-residual disease in PD-1/PD-L1 inhibitors-treated non-small cell lung cancer. Frontiers in Immunology. 15. 1525236–1525236. 1 indexed citations
3.
4.
Zhou, Yuling, Qiang Zhou, Qinghua Yin, et al.. (2024). Role of autophagy-related genes in liver cancer prognosis. Genomics. 116(3). 110852–110852. 3 indexed citations
5.
Hu, Jianbing, Jie Weng, Fang Wen, et al.. (2023). A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer. Frontiers in Endocrinology. 14. 1110624–1110624. 4 indexed citations
6.
Li, Baofeng, et al.. (2023). Prevalence of osteoporosis in spinal surgery patients older than 50 years: A systematic review and meta-analysis. PLoS ONE. 18(5). e0286110–e0286110. 21 indexed citations
7.
Li, Mingyao, et al.. (2022). Age-Related Sex Disparities in Esophageal Cancer Survival: A Population-Based Study in the United States. Frontiers in Public Health. 10. 836914–836914. 7 indexed citations
8.
Li, Mingyao, et al.. (2021). Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database. Oral Oncology. 117. 105284–105284. 9 indexed citations
9.
Shen, Erdong, et al.. (2021). Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy. Bioengineered. 12(1). 1773–1790. 16 indexed citations
10.
Zhang, Liang, Xin Wang, Xin Liu, et al.. (2020). miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer. Acta Biochimica et Biophysica Sinica. 52(8). 842–852. 10 indexed citations
11.
Liu, Xin, Mingyang Xiao, Liang Zhang, et al.. (2020). The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway. Journal of Clinical Laboratory Analysis. 35(3). e23655–e23655. 78 indexed citations
12.
Shen, Erdong, et al.. (2019). Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells. The Kaohsiung Journal of Medical Sciences. 35(8). 474–485. 6 indexed citations
13.
Deng, Liang, Liangfang Shen, Zhao Zhao, et al.. (2019). Prognostic value of magnetic resonance imaging features in low-grade gliomas. Bioscience Reports. 39(6). 6 indexed citations
14.
Jing, Di, Qian Zhang, Erdong Shen, et al.. (2019). RIG‐I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma. Cancer Medicine. 8(14). 6344–6357. 18 indexed citations
15.
16.
Лю, Бо, Erdong Shen, Mingmei Liao, et al.. (2016). Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer. Tumor Biology. 37(7). 9875–9886. 48 indexed citations
17.
Shen, Erdong, et al.. (2016). The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma. OncoTargets and Therapy. 9. 3633–3633. 6 indexed citations
18.
Shen, Erdong, et al.. (2015). Increased serum resistin levels correlate with psoriasis: a meta-analysis. Lipids in Health and Disease. 14(1). 44–44. 30 indexed citations
19.
Meng, Zheying, et al.. (2015). [MicroRNA-182 modulates high glucose-induced cardiomyocyte hypertrophy via targeting Rac1].. PubMed. 43(7). 619–24. 4 indexed citations
20.
Shen, Erdong, et al.. (2013). The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis. Tumor Biology. 35(3). 2529–2535. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeng-Hong Li Breakdown of academic impact, for papers by Chih-Yuan Fang Breakdown of academic impact, for papers by Valeria Denninghoff Breakdown of academic impact, for papers by Hong-Lin Yin Breakdown of academic impact, for papers by Paul‐Yang Lin Breakdown of academic impact, for papers by Junhang Luo Breakdown of academic impact, for papers by Yuenan Huang Breakdown of academic impact, for papers by Ian Y. Luk Breakdown of academic impact, for papers by Xi He
Rankless by CCL
2026